|
skos:pref |
"Sirolimus"@en
|
|
skos:alt |
"Rapamycin"@en
|
| skos:broader | Antibiotics |
|
schema:main |
<https:/ |
|
<http:/ |
|
|
skos:editorial |
"MeSH"@nl |
| "Unrestricted utilization of sirolimus-eluting stents in the "Real World" / Pedro A. Lemos Neto"@nl | |
|
skos:in |
<http:/ |
Inverse relations
[ .. ] → schema:about → Sirolimus
Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models / Arne Roderic Maria van der Biltschema:ProductModel
Beyond chemotherapy: proapoptotic and antiangiogenic drug effects in preclinical ovarian cancer models / Arne Roderic Maria van der Biltschema:ProductModel
Redefining the boundaries of drug-eluting stent utilization: from in-stent restenosis to acute myocardial infarction / Francesco Saiaschema:ProductModel
Redefining the boundaries of drug-eluting stent utilization: from in-stent restenosis to acute myocardial infarction = Het opnieuw vaststellen van de mogelijkheden van de drug-eluting stent: van in-stent restenosis tot acuut myocard infarct / Francesco Saiaschema:ProductModel
Unrestricted utilization of sirolimus-eluting stents in the "Real World": the rapamycin-eluting stent evaluation at Rotterdam Cardiology Hospital (RESEARCH) registry / Pedro A. Lemos Netoschema:ProductModel
Unrestricted utilization of sirolimus-eluting stents in the "Real World": the rapamycin-eluting stent evaluation at Rotterdam Cardiology Hospital (RESEARCH) registry = Onbeperkt gebruik van de met sirolimus gecoate stents in de klinische praktijk. De Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registratie / Pedro A. Lemos Netoschema:ProductModel